510(k) K974809
K974809 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN(TM) 130 BORRELIA BURGDORFERI IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Feb 5, 1998. The device falls under product code LSR (Reagent, Borrelia Serological Reagent), a Class II device regulated under 21 CFR 866.3830. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 5, 1998
- Date Received
- Dec 23, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Reagent, Borrelia Serological Reagent
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.